Yale: Progress in Search for Alopecia Areata Treatment for Adolescents
April 15, 2023
April 15, 2023
NEW HAVEN, Connecticut, April 15 (TNSjou) -- Yale University issued the following news:
A Yale-led clinical trial found that the medicine ritlecitinib appears safe and promising for treating adolescents with a form of often-disfiguring hair loss.
A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial.
Alopecia areata is an aut . . .
A Yale-led clinical trial found that the medicine ritlecitinib appears safe and promising for treating adolescents with a form of often-disfiguring hair loss.
A medication that has been found to effectively treat the skin disease alopecia areata in adults is also successful in treating adolescent patients, according to a Yale-led clinical trial.
Alopecia areata is an aut . . .
